PAMELA TARAPACKI: Open Payments
NPI 1912688920 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 97 payments from 17 companies in 2025. Trend: 2023 $1,537 · 2024 $2,907 · 2025 $1,703
Food & beverage: $1,636Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $432 |
| Janssen Biotech, Inc. | 6 | $293 |
| GENZYME CORPORATION | 10 | $283 |
| Novartis Pharmaceuticals Corporation | 29 | $156 |
| Amgen Inc. | 5 | $103 |
| Incyte Corporation | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| PFIZER INC. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Botanix SB Inc | 2 | $43 |
Products named: TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, OTEZLA, COSENTYX, OPZELURA, LIBTAYO.
Industry payments across NY — which companies pay providers there.
